Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia
Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia Nikolaos Koutsouleris, Clara Vetter, … , Alexandra Korda, Alessandro Bertolino, Stefan Borgwardt, … DOI: 10.1093/brain/awag100 Abstract Efforts to predict schizophrenia risk using biological data have been hampered by the heterogeneity of current “clinical-high-risk” (CHR-P) criteria, which pool phenomenologically and biologically distinct syndromes under […]